Intellia Therapeutics
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.
2
Funding Rounds
$85.0m
Money raised
Overview
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.
-
Website:
- Business model: B2B
- Headquarters: United States
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra**** Ha* | - | - | |
| Lu Ma*** | - | - | - |
| Ro* Ba** | - | - | |
| Ne**** Be*** |
|
- | |
| Je* Do**** |
|
- | linkedin twitter facebook instagram |
Industries
Intellia Therapeutics is active in the following industries:
- Therapeutics
- Biopharmaceutical
- Genetic engineering
- Cell therapy
- Immunotherapy
- Cancer immunotherapy
- Oncology
- Healthcare
- Consumer biotechnology
- Autoimmune disease
- Biomedical engineering
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Internal medicine
- Regenerative medicine
- Medicine
- Genomics
- Genome editing
- Tissue engineering
- Stem cell technology
- Engineering